港股異動 | 中國玻璃(3300.HK)漲6.8% 玻璃期貨大漲
格隆匯7月19日丨中國玻璃(3300.HK)股價繼續走強,現報2.99港元,漲幅6.79%,最新總市值54.12億;月內累計漲幅逾60%。玻璃期貨主力合約繼續拉昇,盤中最高見3163元續刷新高,現報3127元/噸,漲幅2.9%。光大證券指,繼續堅定看好玻璃下半年的價格走勢,玻璃價格再創歷史新高已為大概率事件。21年H1,下游需求延續,生產企業庫存始終低位,淡季不淡,價格屢創新高。而H2通常才為傳統意義的旺季,當前在產產能釋放已較為充分,地產竣工修復大邏輯繼續演繹下,需求仍將維持旺盛,供需料將進一步緊張,玻璃價格中樞有望繼續抬升。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.